A Study of Dotinurad Versus Allopurinol in Participants With Gout (NCT07089875)
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult participants with hyperuricemia associated with gout.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (103 Sites)
Showing the first 25 of 103 sites.
- University of Alabama at Birmingham — Birmingham, Alabama
- Alabama Clinical Therapeutics — Birmingham, Alabama
- Arizona Arthritis & Rheumatology Associates (AARA) - Gilbert — Gilbert, Arizona
- Arizona Arthritis & Rheumatology Associates (AARA) - Glendale — Glendale, Arizona
- Arizona Arthritis & Rheumatology Associates (AARA) - Mesa — Mesa, Arizona
- Del Sol Research Management - Tucson East — Tucson, Arizona
- Del Sol Research Management - Tucson — Tucson, Arizona
- Medvin Clinical Research - Covina — Covina, California
- West Coast Research — Dublin, California
- Infinity Clinical Research — Norco, California
- Amicis Research Center - Balboa — Northridge, California
- Dream Team Clinical Research — Pomona, California
- Velocity Clinical Research - San Bernardino — San Bernardino, California
- Acclaim Clinical Research, Inc. — San Diego, California
- East Bay Rheumatology Medical Group — San Leandro, California
- BTC Network - Encompass Clinical Research — Spring Valley, California
- Cohen Medical Centers — Thousand Oaks, California
- Medvin Clinical Research - Tujunga — Tujunga, California
- Denver Arthritis Clinic - Lowry — Denver, Colorado
- Bradenton Research Center — Bradenton, Florida
- Herco Medical and Research Center, Inc — Coral Gables, Florida
- New Generation of Medical Research — Hialeah, Florida
- Best Quality Research — Hialeah, Florida
- Health Awareness Inc — Jupiter, Florida
- Clinical Research of Center Florida — Lakeland, Florida
📞 Contact the Study Coordinator
Phone: (858) 379-2316
Email: ClinicalTrials@crystalystx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gout
- Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout — Beverly Hills, California
- Gout in the ED and Improving Research Participation — Birmingham, Alabama
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients — Margate, Florida
- Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001. — Sacramento, California
- PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function — Tampa, Florida
- Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) — Birmingham, Alabama
Explore by condition: All Gout clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.